Santa Cruz Biotechnology offers a broad range of MEA-1 monoclonal antibodies to support research needs. MEA-1 monoclonal antibodies are compatible with multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). MEA-1, also known as the melanoma-associated antigen 1, plays a crucial role in the immune response and is often associated with tumor progression. Its expression is linked to various cancers, making MEA-1 an important target for cancer immunotherapy and diagnostics. Understanding MEA-1 function can provide insights into tumor biology and potential therapeutic strategies. MEA-1 monoclonal antibodies enable precise detection and analysis of MEA-1 expression patterns in different tissue types. Researchers can utilize MEA-1 monoclonal antibodies to investigate cellular signaling pathways and molecular mechanisms involved in cancer development. MEA-1 monoclonal antibodies from Santa Cruz Biotechnology contribute to advancing cancer research and therapeutic development within the scientific community.